{"id":775569,"date":"2023-08-04T11:13:32","date_gmt":"2023-08-04T15:13:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/"},"modified":"2023-08-04T11:13:32","modified_gmt":"2023-08-04T15:13:32","slug":"certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/","title":{"rendered":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset"},"content":{"rendered":"

<\/p>\n

Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset<\/b><\/p>\n

Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines.<\/i><\/p>\n

SEOUL, South Korea–(BUSINESS WIRE<\/a>)–
\nCertara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certara\u2019s Pinnacle 21 Enterprise data conformance and submission software<\/a> and SEND Explorer pre-clinical data visualization software<\/a> . The combination of Pinnacle 21 Enterprise and SEND Explorer enables synergy for meeting global regulatory guidelines and delivering efficiency. The technology optimizes data analysis from a regulatory perspective and allows scientists to gain scientific insight through interactive toxicity data visualization. It also ensures FDA submission-ready SEND, SDTM, and ADaM datasets.<\/p>\n

\nPinnacle 21 Enterprise is used to validate compliance with the Clinical Data Interchange Standards Consortium (CDISC) standards, which are required by the U.S. Food & Drug Administration (FDA), Japan\u2019s Pharmaceuticals and Medical Devices Agency (PMDA), and recommended by China\u2019s National Medical Products Administration (NMPA) for evaluating regulatory submissions. Pinnacle 21 Enterprise software has been adopted by the FDA and PMDA as well as 24 of the top 25 biopharmaceutical companies by R&D spend.<\/p>\n

\nSEND Explorer is a validated, web-based application that provides advanced viewing, data summarization and visualization capabilities for nonclinical study data. Using SEND Explorer, scientists generate visualizations of single and multiple toxicology studies to inform decisions and quickly address questions from health authorities.<\/p>\n

\n\u201cWe expect that using Pinnacle 21 Enterprise will help KIT increase the quality of SEND Datasets for submission to regulatory agencies. In addition, SEND Explorer will help KIT provide advanced analysis including historical data and cross-analysis studies of toxicity tests, that enable sponsors to quickly address questions from the FDA.\u201d said Junyong Lee, Korea Country Sales Director at Certara.<\/p>\n

\n\u201cWith SEND Explorer and Pinnacle 21 Enterprise, scientists can more effectively bridge the translational gap between the nonclinical and clinical phases and ensure that they are regulatory ready\u201d added Leif E. Pedersen, President, Software at Certara.<\/p>\n

\nLearn more about Certara software: https:\/\/www.certara.com\/software\/<\/a><\/p>\n

\nAbout Certara<\/p>\n

\nCertara accelerates medicines using proprietary biosimulation software, technology and services that transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230720443872\/en\/<\/a><\/span><\/p>\n

\nEmi Akatsu
\n
Emi.akatsu@certara.com<\/a><\/p>\n

KEYWORDS:<\/b> Asia Pacific South Korea<\/p>\n

INDUSTRY KEYWORDS:<\/b> Science Software Biotechnology Research Pharmaceutical Health Technology Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines. SEOUL, South Korea–(BUSINESS WIRE)– Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certara\u2019s Pinnacle 21 Enterprise data conformance and submission software and SEND Explorer pre-clinical data visualization software . The combination of Pinnacle 21 Enterprise and SEND Explorer enables synergy for meeting global regulatory guidelines and delivering efficiency. The technology optimizes data analysis from a regulatory perspective and allows scientists to gain scientific insight through interactive toxicity data visualization. It also ensures FDA submission-ready SEND, SDTM, and ADaM datasets. … <\/p>\n

Continue reading “Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-775569","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCertara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines. SEOUL, South Korea–(BUSINESS WIRE)– Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certara\u2019s Pinnacle 21 Enterprise data conformance and submission software and SEND Explorer pre-clinical data visualization software . The combination of Pinnacle 21 Enterprise and SEND Explorer enables synergy for meeting global regulatory guidelines and delivering efficiency. The technology optimizes data analysis from a regulatory perspective and allows scientists to gain scientific insight through interactive toxicity data visualization. It also ensures FDA submission-ready SEND, SDTM, and ADaM datasets. … Continue reading "Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-04T15:13:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset\",\"datePublished\":\"2023-08-04T15:13:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/\"},\"wordCount\":422,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/\",\"name\":\"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-08-04T15:13:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/","og_locale":"en_US","og_type":"article","og_title":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset - Market Newsdesk","og_description":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines. SEOUL, South Korea–(BUSINESS WIRE)– Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certara\u2019s Pinnacle 21 Enterprise data conformance and submission software and SEND Explorer pre-clinical data visualization software . The combination of Pinnacle 21 Enterprise and SEND Explorer enables synergy for meeting global regulatory guidelines and delivering efficiency. The technology optimizes data analysis from a regulatory perspective and allows scientists to gain scientific insight through interactive toxicity data visualization. It also ensures FDA submission-ready SEND, SDTM, and ADaM datasets. … Continue reading \"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-04T15:13:32+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset","datePublished":"2023-08-04T15:13:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/"},"wordCount":422,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/","name":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-08-04T15:13:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230720443872r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/certara-collaborates-with-korea-institute-of-toxicology-to-ensure-fda-submission-ready-send-dataset\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=775569"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775569\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=775569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=775569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=775569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}